Noah Berkowitz
CIK: 0001369900
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Sep 30, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
180K shares- - Sep 30, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectPerformance Stock Units
135K shares- - Sep 30, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectStock Options (Right to Buy)
135K shares- - May 11, 2026ARVN
ARVINAS, INC.
Sale(S)Direct11.1K shares at avg. $9.94$110K - Mar 18, 2026ARVN
ARVINAS, INC.
Sale(S)Direct6.4K shares at avg. $11.10$71K - Feb 26, 2026ARVN
ARVINAS, INC.
Award(A)Direct45K shares- - Feb 13, 2026ARVN
ARVINAS, INC.
Sale(S)Direct5.7K shares at avg. $11.89$68K - May 9, 2025ARVN
ARVINAS, INC.
Award(A)Direct59.6K shares- - Mar 18, 2025ARVN
ARVINAS, INC.
Sale(S)Direct8.7K shares at avg. $8.59$74K - Feb 13, 2025ARVN
ARVINAS, INC.
Award(A)Direct55.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Restricted Stock Units | 180,000 | - | - | Direct |
| Sep 30, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Performance Stock Units | 135,000 | - | - | Direct |
| Sep 30, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Stock Options (Right to Buy) | 135,000 | - | - | Direct |
| May 11, 2026 |  ARVN ARVINAS, INC. | Sale(S) | 11,108 | $9.94 | $110,385 | Direct |
| Mar 18, 2026 | ARVN ARVINAS, INC. | Sale(S) | 6,435 | $11.10 | $71,431 | Direct |
| Feb 26, 2026 | ARVN ARVINAS, INC. | Award(A) | 45,000 | - | $0 | Direct |
| Feb 13, 2026 | ARVN ARVINAS, INC. | Sale(S) | 5,685 | $11.89 | $67,595 | Direct |
| May 9, 2025 | ARVN ARVINAS, INC. | Award(A) | 59,600 | - | - | Direct |
| Mar 18, 2025 | ARVN ARVINAS, INC. | Sale(S) | 8,658 | $8.59 | $74,372 | Direct |
| Feb 13, 2025 | ARVN ARVINAS, INC. | Award(A) | 55,229 | - | - | Direct |
1-10 of 10 transactions
About Berkowitz Noah
Berkowitz Noah (SEC CIK 0001369900) files insider reports with the SEC as Chief Medical Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA) and Chief Medical Officer of ARVINAS, INC. (ARVN).
Signal8 holds 9 ownership filings by Berkowitz Noah (1 Form 3, 8 Form 4), filed between Feb 18, 2025 and Oct 2, 2026. Those filings report 10 transactions, from Feb 13, 2025 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Berkowitz Noah's filings is in PHILADELPHIA, PA.
Recent filings by Berkowitz Noah
- Sep 30, 2026: Grants or awards of IOVA derivative securities (3 lines, Form 4, code A).
- May 11, 2026: Open-market sale of ARVN shares (Form 4, code S).
- Mar 18, 2026: Open-market sale of ARVN shares (Form 4, code S).
- Feb 26, 2026: Grant or award of ARVN shares (Form 4, code A).
- Feb 13, 2026: Open-market sale of ARVN shares (Form 4, code S).
Other insiders filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Vogt Frederick G, Interim CEO & General Counsel
- BILINSKY IGOR, Chief Operating Officer
- Puri Raj K., Chief Regulatory Officer
- Kirby Daniel Gordon, Chief Commercial Officer
- Roche Corleen M., Chief Financial Officer
- WEISER MICHAEL, Director